Talk:Etravirine: Difference between revisions

Content deleted Content added

Inline

Revision as of 19:00, 5 February 2008

Medicine Stub‑class Low‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Stub	This article has been rated as Stub-class on Wikipedia's content assessment scale.
Low	This article has been rated as Low-importance on the project's importance scale.

TMC-278 (rilpivirine) is not the same as TMC-125 (etravirine). etravirine has been FDA approved, ripilvirine is still in Phase III trials, AFIK. 128.59.74.3 (talk) 19:00, 5 February 2008 (UTC)[reply]

Revision as of 20:30, 8 December 2007 edit WhatamIdoing (talk \| contribs) Autopatrolled, Extended confirmed users, Pending changes reviewers 116,111 edits m updated wikiproject WPMED «Stub/Low» ← Previous edit		Revision as of 19:00, 5 February 2008 edit undo 128.59.74.3 (talk) No edit summary Next edit →
Line 1:		Line 1:
	{{WPMED\|class=Stub\|importance=Low}}		{{WPMED\|class=Stub\|importance=Low}}

			TMC-278 (rilpivirine) is not the same as TMC-125 (etravirine). etravirine has been FDA approved, ripilvirine is still in Phase III trials, AFIK. [[Special:Contributions/128.59.74.3\|128.59.74.3]] ([[User talk:128.59.74.3\|talk]]) 19:00, 5 February 2008 (UTC)